Management of gram-positive bacterial infections in patients with cancer

References

• Viscoli C. Management of infection in cancer patients. Studies of the EORTC International Antimicrobial Therapy Group (IATG). Eur J Cancer 2002;38(Suppl. 4):S82–S87.
   PubMed Web of Science ®Google Scholar
• Elting LS, Rubenstein EB, Rolston KV, . Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997;25:247–259.
   PubMed Web of Science ®Google Scholar
• Aksu G, Ruhi MZ, Akan H, . Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Bone Marrow Transplant 2001;27:201–205.
   PubMed Web of Science ®Google Scholar
• Gaytan-Martinez J, Mateos-Garcia E, Sanchez-Cortes E, . Microbiological findings in febrile neutropenia. Arch Med Res 2000;31:388–392.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Seifert H, Wenzel RP, . Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36:1103–1110.
   PubMed Web of Science ®Google Scholar
• Rolston KV, Yadegarynia D, Kontoyiannis DP, . The spectrum of gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against gram-positive bacteria isolated from cancer patients. Int J Infect Dis 2006;10:223–230.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Spanu T, Caira M, . Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis 2009;64:320–326.
   PubMed Web of Science ®Google Scholar
• Rubio M, Palau L, Vivas JR, . Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol 1994;15:101–104.
   PubMed Web of Science ®Google Scholar
• Cherif H, Kronvall G, Bjorkholm M, . Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J 2003;4:420–426.
   PubMedGoogle Scholar
• Yadegarynia D, Tarrand J, Raad I, . Current spectrum of bacterial infections in patients with cancer. Clin Infect Dis 2003;37:1144–1145.
   PubMed Web of Science ®Google Scholar
• Raad I, Kassar R, Ghannam D, . Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis 2009;49:1187–1194.
   PubMed Web of Science ®Google Scholar
• Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database—USA. Clin Infect Dis 1999;29:259–263.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Barca E, Carratala J, Mykietiuk A, . Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer. Eur J Clin Microbiol Infect Dis 2001;20:117–119.
   PubMed Web of Science ®Google Scholar
• Gopal AK, Fowler VG Jr, Shah M, . Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. J Clin Oncol 2000;18:1110–1115.
   PubMed Web of Science ®Google Scholar
• Ghanem GA, Boktour M, Warneke C, . Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore) 2007;86:54–60.
   PubMed Web of Science ®Google Scholar
• Venditti M, Falcone M, Micozzi A, . Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study. Haematologica 2003;88:923–930.
   PubMed Web of Science ®Google Scholar
• Bochud PY, Eggiman P, Calandra T, . Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 1994;18:25–31.
   PubMed Web of Science ®Google Scholar
• Richard P, Amador Del Valle G, Moreau P, . Viridans streptococcal bacteraemia in patients with neutropenia. Lancet 1995;345:1607–1609.
   PubMed Web of Science ®Google Scholar
• Engelhard D, Elishoov H, Or R, . Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study. Bone Marrow Transplant 1995;16:565–570.
   PubMed Web of Science ®Google Scholar
• Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992;14:1201–1207.
   PubMed Web of Science ®Google Scholar
• Ringden O, Heimdahl A, Lonnqvist B, . Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir. Lancet 1984;1:744.
   PubMed Web of Science ®Google Scholar
• Collin BA, Leather HL, Wingard JR, . Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001;33: 947–953.
   PubMed Web of Science ®Google Scholar
• Bilgrami S, Feingold JM, Dorsky D, . Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1998;21:591–595.
   PubMed Web of Science ®Google Scholar
• Prabhu RM, Piper KE, Litzow MR, . Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis. Eur J Clin Microbiol Infect Dis 2005;24:832–838.
   PubMed Web of Science ®Google Scholar
• Razonable RR, Litzow MR, Khaliq Y, . Bacteremia due to viridans group Streptococci with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis 2002;34:1469–1474.
   PubMed Web of Science ®Google Scholar
• Guthrie KA, Yong M, Frieze D, . The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2010;45:675–681.
   PubMed Web of Science ®Google Scholar
• Kruger WH, Bohlius J, Cornely OA, . Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology. Ann Oncol 2005;16:1381–1390.
   PubMed Web of Science ®Google Scholar
• Matar MJ, Tarrand J, Raad I, . Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 2006;34:534–536.
   PubMed Web of Science ®Google Scholar
• Todeschini G, Tecchio C, Borghero C, . Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies. J Infect 2006;53:266–273.
   PubMed Web of Science ®Google Scholar
• Venditti M, Tarasi A, Visco Comandini U, . Enterococcal septicemia in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1993;12:241–247.
   PubMed Web of Science ®Google Scholar
• Worth LJ, Thursky KA, Seymour JF, . Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 2007;79:226–233.
   PubMed Web of Science ®Google Scholar
• Dubberke ER, Hollands JM, Georgantopoulos P, . Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? Bone Marrow Transplant 2006;38:813–819.
   PubMed Web of Science ®Google Scholar
• Avery R, Kalaycio M, Pohlman B, . Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant 2005;35:497–499.
   PubMed Web of Science ®Google Scholar
• Zeana, C, Kubin CJ, Della-Latta P, . Vancomycin-resistant enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin Infect Dis 2001;33:477–82.
   PubMed Web of Science ®Google Scholar
• Le J, Bookstaver B, Rudisill CN, . Treatment of meningitis caused by vancomycin-resistant enterococcus faecium: high-dose and combination daptomycin therapy. Ann Pharmacother 2010;44:2001–2006.
   PubMed Web of Science ®Google Scholar
• Scapellato PG, Ormazabal C, Scapellato JL, . Meningitis due to vancomycin-resistant enterococcus faecium successfully treated with combined intravenous and intraventricular chloramphenicol. J Clin Microbiol 2005;43:3578–3579.
   PubMed Web of Science ®Google Scholar
• Anaissie E, Kontoyiannis DP, Kantarjian H, . Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone. Ann Intern Med 1992;117:466–469.
   PubMed Web of Science ®Google Scholar
• Rivero GA, Torres HA, Rolston KV, . Listeria monocytogenes infection in patients with cancer. Diagn Microbiol Infect Dis 2003; 47:393–398.
   PubMed Web of Science ®Google Scholar
• Merle-Melet M, Dossou-Gbete L, Maurer P, . Is amoxicillin-cotrimoxazole the most appropriate antibiotic regimen for Listeria meningoencephalitis? Review of 22 cases and the literature. J Infect 1996;33:79–85.
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes. 33 years’ experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore) 1998;77:313–336.
   PubMed Web of Science ®Google Scholar
• Torres HA, Reddy BT, Raad II, . Nocardiosis in cancer patients. Medicine (Baltimore) 2002;81:388–397.
   PubMed Web of Science ®Google Scholar
• van Burik JA, Hackman RC, Nadeem SQ, . Nocardiosis after bone marrow transplantation: a retrospective study. Clin Infect Dis 1997;24:1154–1160.
   PubMed Web of Science ®Google Scholar
• Bobak D, Arfons LM, Creger RJ, . Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplant 2008; 42:705–713.
   PubMed Web of Science ®Google Scholar
• Chopra T, Salimnia H, Merline J, . Current epidemiology of Clostridium difficile associated disease (CDAD) in hematopoietic stem cell transplant recipients (HSCTR). Presented at 45th Annual Meeting of Infectious Diseases Society of America, 2007, San Diego, CA.
   Google Scholar
• Chopra T, Alangaden GJ, Chandrasekar P. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther 2010;8:1113–1119.
   PubMed Web of Science ®Google Scholar
• Batlle M, Vall-Llovera F, Bechini J, . [Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases]. Med Clin (Barc) 2007;129:660–663.
   PubMed Web of Science ®Google Scholar
• King A, Wight DG. Clostridium septicum and neutropenic enterocolitis. Lancet 1987;2:1279.
   PubMed Web of Science ®Google Scholar
• Hopkins DG, Kushner JP. Clostridial species in the pathogenesis of necrotizing enterocolitis in patients with neutropenia. Am J Hematol 1983;14:289–295.
   PubMed Web of Science ®Google Scholar
• El-Masry S. Spontaneous gas gangrene associated with occult carcinoma of the colon: a case report and review of literature. Int Surg 2005;90:245–247.
   PubMed Web of Science ®Google Scholar
• Mohamed HK, Elliott BM, Brothers TE, . Suprarenal Clostridium septicum aortitis with rupture and simultaneous colon cancer. Ann Vasc Surg 2006;20:825–829.
   PubMed Web of Science ®Google Scholar
• Mirza NN, McCloud JM, Cheetham MJ. Clostridium septicum sepsis and colorectal cancer - a reminder. World J Surg Oncol 2009;7:73.
   PubMed Web of Science ®Google Scholar
• Lorimer JW, Eidus LB. Invasive Clostridium septicum infection in association with colorectal carcinoma. Can J Surg 1994;37: 245–249.
   PubMed Web of Science ®Google Scholar
• Schickner DC, Yarkoni A, Langer P, . Panophthalmitis due to Clostridium septicum. Am J Ophthalmol 2004;137:942–944.
   PubMed Web of Science ®Google Scholar
• Chew SS, Lubowski DZ. Clostridium septicum and malignancy. ANZ J Surg 2001;71:647–649.
   PubMed Web of Science ®Google Scholar
• Ghide S, Jiang Y, Hachem R, . Catheter-related Corynebacterium bacteremia: should the catheter be removed and vancomycin administered? Eur J Clin Microbiol Infect Dis 2010;29: 153–156.
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, . Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1–45.
   PubMed Web of Science ®Google Scholar
• Kassar R, Hachem R, Jiang Y, . Management of Bacillus bacteremia: the need for catheter removal. Medicine (Baltimore) 2009;88:279–283.
   PubMed Web of Science ®Google Scholar
• Cotton DJ, Gill VJ, Marshall DJ, . Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population. J Clin Microbiol 1987;25: 672–674.
   PubMed Web of Science ®Google Scholar
• Ramos ER, Hachem R, Youssef S, . The crucial role of catheters in micrococcal bloodstream infections in cancer patients. Infect Control Hosp Epidemiol 2009;30:83–85.
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Dale DC, Crawford J, . Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006;106:2258–2266.
   PubMed Web of Science ®Google Scholar
• Mustafa MM, Carlson L, Tkaczewski I, . Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J 2001;20:362–369.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP, . 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730–751.
   PubMed Web of Science ®Google Scholar
• Sakoulas G, Moise-Broder PA, Schentag J, . Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004;42:2398–2402.
   PubMed Web of Science ®Google Scholar
• Rybak MJ, Lomaestro BM, Rotscahfer JC, . Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009;49:325–327.
   PubMed Web of Science ®Google Scholar
• Morris A, Ward C. High incidence of vancomycin-associated leucopenia and neutropenia in a cardiothoracic surgical unit. J Infect 1991;22:217–223.
   PubMed Web of Science ®Google Scholar
• Hope R, Livermore DM, Brick G, . Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001–06. J Antimicrob Chemother 2008;62(Suppl. 2):ii65–ii74.
   PubMed Web of Science ®Google Scholar
• Hahn-Ast C, Glasmacher A, Arns A, . An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant? Infection 2008;36: 54–58.
   PubMed Web of Science ®Google Scholar
• Chow AW, Jewesson PJ, Kureishi A, . Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients. Eur J Haematol Suppl 1993;54:18–24.
   PubMedGoogle Scholar
• Ziglam HM, Gelly K, Olver W. A survey of the management of neutropenic fever in oncology units in the UK. Int J Antimicrob Agents 2007;29:430–433.
   PubMed Web of Science ®Google Scholar
• Jaksic B, Martinelli G, Perez-Oteyza J, . Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer. Clin Infect Dis 2006;42:597–607.
   PubMed Web of Science ®Google Scholar
• Rolston KV, McConnell SA, Brown J, . Daptomycin use in neutropenic patients with gram-positive bacteremia. Blood 2008;112(Suppl. 1): Abstract 1475.
   Google Scholar
• Sakoulas G. Daptomycin for soft tissue infection and neutropenia in a myelogenous leukemia patient who failed prior vancomycin therapy. Clin Adv Hematol Oncol 2008;6:813–815.
   PubMedGoogle Scholar
• Poutsiaka DD, Skiffington S, Miller KB, . Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J Infect 2007;54:567–571.
   PubMed Web of Science ®Google Scholar
• Bubalo JS, Munar MY, Cherala G, . Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever. Antimicrob Agents Chemother 2009;53:428–434.
   PubMed Web of Science ®Google Scholar
• Long JK, Choueiri TK, Hall GS, . Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia. Mayo Clin Proc 2005;80:1215–1216.
   PubMed Web of Science ®Google Scholar
• Chemaly RF, Hanmod SS, Jiang Y, . Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore) 2009;88:211–220.
   PubMed Web of Science ®Google Scholar
• Saravolatz LD, Stein GE, Johnson LB. Telavancin: a novel lipoglycopeptide. Clin Infect Dis 2009;49:1908–1914.
   PubMed Web of Science ®Google Scholar